Thesis TrackerLoading companies…
All companies
Loading…
Thesis TrackerThesis TrackerLoading…
ImExHS (ASX:IME), a medical imaging software company, raised capital that EGP Capital supported. In March 2024, EGP reported ImExHS, one of its smaller holdings, raised a small amount of capital, and that it applied for enough stock to avoid dilution. ImExHS operates in the Healthcare sector within the Health Care Technology industry, and Thesis Tracker has captured 1 comment from 1 fund manager, EGP Capital. ImExHS develops and sells the Hiruko software platform, a cloud-based modular imaging system that includes radiology information systems, picture archiving and communication systems and cardiology information systems, along with imaging services, serving hospitals and clinics in Latin America, particularly Colombia, and other markets.
Company figures as of 15 Oct 2026. For information only.
Fund managers including EGP Capital have invested in ImExHS Ltd (ASX:IME).
EGP's participation in the capital raise indicates continued support for ImExHS' imaging software growth in Latin America.
The need to raise capital highlights ImExHS' funding requirements as a small company.
ImExHS Ltd. develops and sells the Hiruko software platform, a modular imaging system featuring a radiology information system, cardiology information system, anatomical pathology and laboratory information system, and picture archiving and communications system. Founded in 2012 by German Arango, Jorge Marin, Andres Vanegas, and Alexander Sanz, the company is headquartered in Mascot, Australia.
General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.
11,356 comments from 164 managers on 761 companies, snapshot 15 Oct 2026.